SECsense Logo

Beam Therapeutics Inc. 8-K Filing Report: Key Insights & Details

$BEAM
Form 8-K
Filed on: 2025-01-13
Source
Beam Therapeutics Inc. 8-K Filing Report: Key Insights & Details

Here are the key insights extracted from the provided section of the financial report:

  1. XML Structure: The report is structured in XBRL (eXtensible Business Reporting Language), which is commonly used for financial data reporting to the SEC.
  2. Entity Information:
  • Company Name: Beam Therapeutics Inc.
  • CIK Number: 0001745999 (Central Index Key used by the SEC for company identification).
  • SEC File Number: 001-39208.
  • IRS Employer Identification Number (EIN): 81-5238376.
  1. Contact Information:
  • Address: 238 Main Street, Cambridge, MA 02142.
  • Phone Number: 857-327-8775.
  1. Report Type: This filing is an 8-K, which is used to report major events that shareholders should know about.
  2. Filing Date: The report is dated January 13, 2025.
  3. Common Stock Information:
  • Stock Par Value: $0.01 per share.
  • Stock Ticker: BEAM.
  • Exchange: NASDAQ.
  1. Period of Reporting: The reporting period is a single day, January 13, 2025.
  2. XML Declaration: The document begins with an XML declaration indicating it is an XML file encoded in UTF-8.

Overall, the document is an 8-K filing by Beam Therapeutics Inc., reporting a specific event on January 13, 2025, and includes vital identification and stock information about the company. Further details would be needed to understand the specific events or changes being reported in the 8-K.